GBS Inc. Enters Sponsored Research Agreement with Johns Hopkins Bloomberg School of Public Health To Accelerate Development of Saliva-Based Diagnostic Tests
New York, NY, February 18, 2021 – GBS Inc. (Nasdaq: GBS), a life sciences company that develops non-invasive, real-time point of care (POC) diagnostic tests for patients and their primary health practitioners, today announced the execution of a sponsored research agreement with Johns Hopkins Bloomberg School of Public Health to accelerate development of next-generation saliva-based diagnostic tests. […]
Harvard’s Wyss Institute collaborates with GBS Inc. on the Wyss’ eRapid-based COVID-19 diagnostic to help curb the pandemic
Combination of the Wyss’ electrochemical sensing technology with GBS’s transistor technology could enable fast, multiplexed, low-cost COVID-19 biomarker analysis in point-of-care applications. This article has been republished with permission from the Wyss Institute at Harvard University. Click here to view the original article. By Benjamin Boettner (BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard […]
The iQ Group Global raises more than $1 million for cancer research
Vital research into children’s cancer has been bolstered through generous donations at the 2020 Tour de Cure Spring Lunch, with more than $1 million raised. Sponsored by presenting partner The iQ Group Global, the annual event received a raft of donations and support, with performances by Delta Goodrem, Matthew Copley and Prinnie Stevens. Channel Seven’s […]
Harvard’s Wyss Institute licenses its eRapid technology to The iQ Group Global to accelerate the development of COVID-19 diagnostics
The low-cost electrochemical technology for multiplexed biomarker detection could facilitate global serological testing for SARS-CoV-2 infections, and help trace immunity in individuals over time. This article has been republished with permission from the Wyss Institute at Harvard University. Click here to view the original article. By Benjamin Boettner (BOSTON) — Today, the Wyss Institute for […]
World Diabetes Day 2020: The crucial role of nurses and health professionals in diabetes
As the number of people with diabetes continues to rise across the world, the role of nurses and other health professionals is crucial in managing the impact of the condition, the International Federation of Diabetes (IDF) urged this World Diabetes Day. With the theme ‘The Nurse and Diabetes’, the campaign on November 14 raised awareness of […]
The iQ Group Global named one of Australia’s Most Innovative Companies for second consecutive year
The iQ Group Global is honoured to be recognised as one of Australia and New Zealand’s Most Innovative Companies for the second year in a row. The prestigious annual list, published by The Australian Financial Review and Boss Magazine, is based on a rigorous assessment process managed by Australia’s leading innovation consultancy, Inventium, in conjunction […]
Disease, Detection and DNA: What your saliva says about you
Research has shown that human saliva holds a treasure trove of data related to human biology and genetics. This aids in the diagnosis and monitoring of disease and adds to a health professionals’ arsenal in determining the most appropriate ways to detect and treat diseases. Research conducted by the Johns Hopkins University Centre for Interdisciplinary […]
This National Diabetes Week, it’s time to talk about diabetes and mental health
New research has shown that up to 50% of people living with diabetes are thought to suffer from depression or anxiety, with more than 20% most worried about the constant burden of daily diabetes management, including glucose monitoring. Conducted by Diabetes Australia, the research brings to light the significant mental and emotional health impact of diabetes as […]
The iQ Group Global collaborates with Harvard University’s Wyss Institute to explore the feasibility of a real-time, printable COVID-19 diagnostic test
The iQ Group Global has entered into a material transfer agreement with Harvard University’s Wyss Institute to explore whether a proprietary technology developed at the Wyss Institute could be used to help provide a printable point-of-care SARS-CoV-2 antibody test for the COVID-19 disease that could produce results in real-time. Life Science Biosensor Diagnostics Pty Ltd […]
EXPLAINER: Are point-of-care tests the answer to managing COVID-19 without a vaccine?
By Athena Kolivos, Chief Scientific Officer CRC and Farmaforce Imagine if you could be tested for SARS-CoV-2, the virus that causes the COVID-19 disease, at your local pharmacy, GP or in your own home, and receive results then and there. Point-of-Care Testing (PoCT) provides patients the ability to receive accurate and reliable testing results outside […]